Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shing Hu

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Biochemistry|June 30, 2004
Characterization of TAT-mediated transport of detachable kinase substratesJoseph S Soughayer, Yan Wang, Huaina Li, et al.
Developmental Cell|March 27, 2024
Villus myofibroblasts are developmental and adult progenitors of mammalian gut lymphatic musculatureBhargav D Sanketi, Madhav Mantri, Liqing Huang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 25, 2017
Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcriptionChunyan Luo, Elisabeth Pook, Bo Tang, et al.
Cell Reports|November 24, 2021
The asymmetric Pitx2 gene regulates gut muscular-lacteal development and protects against fatty liver diseaseShing Hu, Aparna Mahadevan, Isaac F Elysee, et al.
Gene|May 24, 2020
ADTRP regulates TFPI expression via transcription factor POU1F1 involved in coronary artery diseaseChunyan Luo, Elisabeth Pook, Fan Wang, et al.
Molecular Oncology|April 27, 2020
RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumorsXi Yuan, Zhiyu Tang, Rong Du, et al.
Journal of Medicinal Chemistry|October 26, 2021
Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2ALars Wortmann, Nico Bräuer, Simon J Holton, et al.
Molecular Cancer Therapeutics|July 26, 2015
BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal CancersZhiyu Tang, Xi Yuan, Rong Du, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Biochemistry|June 30, 2004
Characterization of TAT-mediated transport of detachable kinase substratesJoseph S Soughayer, Yan Wang, Huaina Li, et al.
Developmental Cell|March 27, 2024
Villus myofibroblasts are developmental and adult progenitors of mammalian gut lymphatic musculatureBhargav D Sanketi, Madhav Mantri, Liqing Huang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 25, 2017
Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcriptionChunyan Luo, Elisabeth Pook, Bo Tang, et al.
Cell Reports|November 24, 2021
The asymmetric Pitx2 gene regulates gut muscular-lacteal development and protects against fatty liver diseaseShing Hu, Aparna Mahadevan, Isaac F Elysee, et al.
Gene|May 24, 2020
ADTRP regulates TFPI expression via transcription factor POU1F1 involved in coronary artery diseaseChunyan Luo, Elisabeth Pook, Fan Wang, et al.
Molecular Oncology|April 27, 2020
RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumorsXi Yuan, Zhiyu Tang, Rong Du, et al.
Journal of Medicinal Chemistry|October 26, 2021
Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2ALars Wortmann, Nico Bräuer, Simon J Holton, et al.
Molecular Cancer Therapeutics|July 26, 2015
BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal CancersZhiyu Tang, Xi Yuan, Rong Du, et al.
Pageof 2